Rhythm Pharmaceuticals (RYTM) Enterprise Value Growth (3y) (2019 - 2026)
Rhythm Pharmaceuticals (RYTM) Enterprise Value Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rhythm Pharmaceuticals | 6.98 Bn | 6.64 Bn | 52.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.92% |
| Dec 31, 2025 | -5.25% |
| Sep 30, 2025 | -30.86% |
| Jun 30, 2025 | -7.31% |
| Mar 31, 2025 | -9.23% |
| Dec 31, 2024 | -2.79% |
| Sep 30, 2024 | 3.12% |
| Jun 30, 2024 | 4.63% |
| Mar 31, 2024 | 20.75% |
| Dec 31, 2023 | -16.83% |
| Sep 30, 2023 | -63.88% |
| Jun 30, 2023 | -62.21% |
| Mar 31, 2023 | -73.80% |
| Dec 31, 2022 | -4.44% |
| Sep 30, 2022 | -69.03% |
| Jun 30, 2022 | -54.87% |
| Mar 31, 2022 | -78.51% |
| Dec 31, 2021 | -80.80% |
| Sep 30, 2021 | -6.43% |
| Jun 30, 2021 | -8.59% |